Key Takeaways
- Intel shares climbed an additional 2.8% in Monday’s premarket session, extending Friday’s explosive 24% rally following first-quarter results.
- First-quarter earnings per share reached $0.29, vastly exceeding the $0.01 Wall Street consensus, while revenue of $13.58B topped the $12.32B forecast.
- Company executives described AI server CPU demand as “unprecedented,” identifying it as the primary catalyst for outperformance.
- UBS elevated its price target to $83 while maintaining a Neutral stance, noting Intel’s forward P/E of 71x appears elevated compared to AMD’s 42x and Nvidia’s 23x.
- Intel received validation for its foundry strategy as Tesla confirmed plans to utilize Intel’s 14A manufacturing process for Terafab AI silicon.
Intel (INTC) is experiencing a remarkable resurgence. Shares advanced 2.8% during Monday’s premarket session to $84.84, extending Friday’s dramatic 24% climb triggered by quarterly results that forced Wall Street to recalibrate its outlook.
The financial performance spoke volumes. Intel delivered first-quarter earnings of $0.29 per share versus the meager $0.01 consensus forecast. Revenue reached $13.58 billion, significantly surpassing the $12.32 billion anticipated by analysts. This represents a year-over-year increase of 7.4%.
The semiconductor giant attributed the outperformance to explosive growth in CPU demand for artificial intelligence server applications. Company leadership characterized current AI workload-related CPU demand as “unprecedented.”
Management also provided encouraging second-quarter guidance, projecting EPS of $0.20 with revenue estimates considerably above analyst expectations.
The equity has appreciated more than fourfold over the trailing twelve months. Monday’s opening price of $82.37 positioned the stock near its 52-week peak of $85.22, a stark contrast to the $18.97 level from a year earlier.
Wall Street’s Response
Analyst revisions arrived swiftly following the earnings release. HSBC elevated Intel from Hold to Buy while boosting its price objective from $50 to $95. Raymond James upgraded from Hold to Moderate Buy. Barclays increased its target to $65 from $45 while retaining an Equal Weight recommendation. The consensus rating currently stands at Hold with a mean price target of $72.98.
However, skepticism persists in certain quarters. UBS analyst Timothy Arcuri increased his target to $83 from $65 but maintained his Neutral position. He highlighted concerns regarding Intel’s forward P/E ratio of approximately 71x, which appears inflated relative to AMD’s 42x and Nvidia‘s 23x.
“We have underestimated how much the market was willing to overlook a lack of earnings power,” Arcuri wrote.
This observation merits consideration. The current valuation assumes flawless execution ahead.
Manufacturing Momentum
Intel’s foundry ambitions received significant validation when Tesla indicated its intention to leverage Intel’s 14A manufacturing technology for Terafab AI processors. This represents a marquee customer acquisition that bolsters the credibility of Intel’s manufacturing turnaround narrative.
Institutional capital has been flowing into the name. Vanguard expanded its holdings by 3.5% during the fourth quarter, now controlling more than 404 million shares. Capital World Investors increased its stake by 32.5% in the third quarter. Institutional ownership currently represents 64.53% of outstanding shares.
Short interest expanded approximately 20.9% in mid-April to roughly 144 million shares, accounting for about 2.9% of the float. The days-to-cover ratio remains modest at approximately 1.2 days.
On the insider front, EVP April Miller Boise divested 20,000 shares in February at $49.05, trimming her position by roughly 15%.
Intel’s market capitalization currently stands at approximately $411 billion. Full-year consensus earnings estimates average $0.08 per share.


